How can genetic differences affect a patient’s response to warfarin?

In the context of therapeutics, genetic differences significantly influence how a patient responds to warfarin, a commonly prescribed anticoagulant.

Individual variations in the enzymes responsible for metabolizing warfarin can alter a patient's sensitivity to the drug. Through the application of personalized medicine, physicians can use genotyping to identify these specific genetic variations. This information is critical for guiding clinical decisions regarding the appropriate dosage required to achieve the desired therapeutic effect while minimizing the risk of complications, such as uncontrollable hemorrhage.1

By tailoring the dosage based on a patient's unique genetic profile, healthcare providers can improve the safety and efficacy of warfarin therapy, moving away from a "one-size-fits-all" approach to treatment.1